23 Jul, 2026
According to Straits Research, the global hyperpigmentation treatment market size was valued at $1.46 billion in 2025 and is projected to reach $2.55 billion by 2034, at a CAGR of 6.45% during the forecast period 2026–2034.
The market growth is primarily attributed to the rising prevalence of pigmentation disorders, advancements in laser and light-based therapies, as well as the introduction of topical formulations with natural as well as biotech-derived actives. In addition, technology innovations in lasers as well as energy-based devices have elevated the precision, safety, and accessibility of hyperpigmentation treatments, which further enhances the market growth. For example, in 2024, as per the Candela Corporation, the company introduced the PicoWay Resolve Fusion, which is a new laser device offering enhanced precision in pigmentation treatment. Such innovations are a major growth factor for clinics, healthcare providers, and the broader aesthetic dermatology industry. Moreover, the transition towards gentle, clean, or often plant-based or biotech-derived solutions in skin care presents as a significant market opportunity as these ingredients are safer, more inclusive, and often align with the demand for sustainable and natural beauty. For example, in March 2024, Givaudan Active Beauty launched Illuminyl 38, a biotech-enhanced molecule designed via cell-free glycosylation that addresses all the challenges of skin pigmentation for all skin types. Such a factor opens new avenues for brands to meet the evolving consumer values as well as regulatory trends.
North America dominated the global hyperpigmentation treatment market, accounting for 52.86% of the market share in 2025. The region's leadership is driven by the presence of well-established dermatology clinics, advanced cosmetic treatment centers, and high consumer awareness regarding skin health and aesthetic procedures. The United States remains the largest contributor, supported by favorable regulatory approvals for innovative topical formulations and laser-based therapies, increasing healthcare expenditure, and strong adoption of personalized skincare solutions. Moreover, the growing prevalence of pigmentation disorders and the availability of technologically advanced treatment options continue to strengthen the regional market.
Asia-Pacific is expected to register the fastest CAGR of 8.26% during the forecast period. The region's rapid growth is attributed to its large population, increasing disposable incomes, and rising awareness of dermatological health and skincare. Countries such as China, Japan, South Korea, and India are witnessing growing demand for advanced hyperpigmentation treatments, supported by the expanding beauty and skincare industry. Furthermore, the increasing adoption of AI-powered skin analysis technologies, personalized skincare products, and public awareness campaigns promoting skin health are accelerating market growth across the region.
sales@straitsresearch.com